Di Filippo, Massimiliano
de Iure, Antonio
Giampà, Carmela
Chiasserini, Davide
Tozzi, Alessandro
Orvietani, Pier Luigi
Ghiglieri, Veronica
Tantucci, Michela
Durante, Valentina
Quiroga-Varela, Ana
Mancini, Andrea
Costa, Cinzia
Sarchielli, Paola
Fusco, Francesca Romana
Calabresi, Paolo
Article History
Received: 27 August 2015
Accepted: 13 January 2016
First Online: 18 February 2016
Change Date: 13 April 2016
Change Type: Update
Change Details: A correction has been published and is appended to both the HTML and PDF versions of this paper. The error has been fixed in the paper.
Competing interests
: M.D.F. participated to advisory boards of Biogen Idec, Teva and Bayer, received travel grants from Bayer Schering, Biogen-Dompé, Biogen-Idec, Merck-Serono, Novartis and Sanofi-Aventis to attend national and international conferences and speaker and writing honoraria from Biogen Idec, Novartis and Sanofi-Genzyme. PC received/receive research support from Bayer Schering, Biogen-Dompé, Boehringer Ingelheim, Eisai, Lundbeck, Merck-Serono, Novartis, Sanofi-Aventis, Sigma-Tau, and UCB Pharma. He also receives/received support from Fondazione Santa Lucia IRCCS, European Community Grant REPLACES (restorative plasticity at corticostriatal excitatory synapses), the Italian Minister of Health, and AIFA (Agenzia Italiana del Farmaco). AdI, CG, DC, AT, PLO, VG, MT, VD, AQV, AM, CC, PS, FRF report no conflicts of interests.